<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Urology reports (St. - Petersburg)</journal-id><journal-title-group><journal-title xml:lang="en">Urology reports (St. - Petersburg)</journal-title><trans-title-group xml:lang="ru"><trans-title>Урологические ведомости</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Urology reports (St. - Petersburg)</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2225-9074</issn><issn publication-format="electronic">2687-1416</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2491</article-id><article-id pub-id-type="doi">10.17816/uroved233-7</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Classification of overactive bladder depending on severity of symptoms</article-title><trans-title-group xml:lang="ru"><trans-title>Классификация гиперактивности мочевого пузыряпо степени тяжести симптоматики</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kuzmin</surname><given-names>Igor Valentinovich</given-names></name><name xml:lang="ru"><surname>Кузьмин</surname><given-names>Игорь Валентинович</given-names></name></name-alternatives><bio xml:lang="en"><p>doctor of medical science, professor, department of urology</p></bio><bio xml:lang="ru"><p>д. м. н., профессор, кафедра урологии</p></bio><email>kuzminigor@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Al-Shukri</surname><given-names>Salman Hasunovich</given-names></name><name xml:lang="ru"><surname>Аль-Шукри</surname><given-names>Сальман Хасунович</given-names></name></name-alternatives><bio xml:lang="en"><p>doctor of medical science, professor, head of the department of urology</p></bio><bio xml:lang="ru"><p>д. м. н., профессор, зав. кафедрой урологии</p></bio><email>al-shukri@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">St.-Petersburg State I. P. Pavlov Medical University</institution></aff><aff><institution xml:lang="ru">Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2012-09-15" publication-format="electronic"><day>15</day><month>09</month><year>2012</year></pub-date><volume>2</volume><issue>3</issue><issue-title xml:lang="en">VOL 2, NO3 (2012)</issue-title><issue-title xml:lang="ru">ТОМ 2, №3 (2012)</issue-title><fpage>3</fpage><lpage>7</lpage><history><date date-type="received" iso-8601-date="2016-03-30"><day>30</day><month>03</month><year>2016</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2012, Kuzmin I.V., Al-Shukri S.H.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2012, Кузьмин И.В., Аль-Шукри С.Х.</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="en">Kuzmin I.V., Al-Shukri S.H.</copyright-holder><copyright-holder xml:lang="ru">Кузьмин И.В., Аль-Шукри С.Х.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2015-09-15"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/uroved/article/view/2491">https://journals.eco-vector.com/uroved/article/view/2491</self-uri><abstract xml:lang="en"><p>Aim of the study: To devise the method of evaluating severity of symptoms in patients with overactive bladder (OAB). Patients and methods: The severity of symptoms was assessed in 533 patients with OAB (the mean age 56,4 ± 0,6 years). All the patients filled the voiding diaries during 3 days, some of them assessed quality of life with KHQ questionnaire and had full urodynamic investigation. Results: The statistical analysis allowed to identify three levels of severity of OAB symptoms, determined in accordance with a score (S). S = 2 × number of voiding (pro 3 days) + number of urgency incidences (pro 3 days) + 1* (* — in case of urge incontinence). The score less than 62 defined as 1st (light) severity, between 63 and 80 —2nd (moderate) severity, more than 80 — 3rd (severe).Severity of OAB significantly correlated with urodynamic changes and quality of life deterioration. Conclusion: The devised method reproduced severity of OAB symptoms is simple and seems to be suitable for widespread use</p></abstract><trans-abstract xml:lang="ru"><p>Цель исследования. Разработать систему оценки тяжести симптоматики у больных с гиперактивностью мочевого пузыря (ГАМП). Пациенты и методы. Проведена оценка тяжести симптоматики у 533 больных с ГАМП (средний возраст 56,4 ± 0,6 года). Все пациенты заполняли дневники мочеиспускания в течение 3 дней, ряду больных оценивали качество жизни по анкетам KHQ и выполняли комплексное уродинамическое исследование. Результаты. Проведенный статистический анализ позволил выделить три степени тяжести симптоматики ГАМП, которые определяли в соответствии с суммой баллов (S), высчитываемой по формуле: S = 2 × число мочеиспусканий за 3 суток + число императивных позывов за 3 суток + 1 * (* — при наличии ургентного недержания мочи). При сумме баллов 62 и менее диагностировали 1-ю (легкую) степень тяжести, от 63 до 80 баллов — 2-ю (умеренную) степень, более 80 баллов — 3-ю (тяжелую) степень. Степень тяжести ГАМП коррелировала с выраженностью уродинамических нарушений и ухудшения качества жизни больных. Заключение. Разработанная система оценки отражает тяжесть клинических проявлений ГАМП, она проста в использовании и представляется весьма полезной для широкого применения</p></trans-abstract><kwd-group xml:lang="en"><kwd>overactive bladder</kwd><kwd>voiding diary</kwd><kwd>quality of life</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>гиперактивность мочевого пузыря</kwd><kwd>дневник мочеиспускания</kwd><kwd>качество жизни</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Аль-Шукри С. Х., Кузьмин И. В. Императивные позывы к мочеиспусканию — ведущий симптом гиперактивности мочевого пузыря / В сб.: Материалы IV Международной научно-практической конференции «Малоинвазивные методы диагностики и лечения в современной урологии». С-Петербург. 2007. C. 31–32.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Аляев Ю. Г., Балан В. Е., Гаджиева З. К. Распространенность императивных нарушений мочеиспускания среди женщин старше 40 лет / В сб.: Материалы Пленума Всероссийского о-ва урологов. Тюмень. 2005. C. 356–357.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Кузьмин И. В. Оценка качества жизни у больных с гиперактивностью мочевого пузыря // Нефрол. 2006. Т. 10, № 4. С. 93–97.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Данилов В. В., Вольных И. Ю., Данилова Т. И. и др. Обоснование сроков назначения М-холинолитиков при консервативном лечении гиперактивного мочевого пузыря // Урол. 2006. № 5. С. 71–74.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Abrams P., Kelleher C. J., Kerr L. A., Rogers R. G. Overactive bladder significantly affects quality of life // Am J Manag Care. 2000. N 6. P. 580–590.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Abrams P., Cardozo L., Fall M. et al. The standardization of terminology in lower urinary tract function: report from the Standardization Sub-Committee of the International Continence Society // Urology. 2003. Vol. 61, N 1. P. 37–49.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Abrams P. Urgency: the key to defining the overactive bladder // BJU Int. 2005. Vol. 96 (Suppl. 1). P. 1–3.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Blaivas J. G., Panagopoulos G., Weiss J. P. et al. The urgency perception score: validation and test-retest // J Urol. 2007. Vol. 177, N 1. P. 199–202.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Cardozo L., Coyne K. S., Versi E. Validation of the urgency perception scale // BJU Int. 2005. Vol. 95, N 4. P. 591–596.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Chapple C. R., Artibani W., Cardozo L. D. et al. The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: current concepts and future prospects // BJU Int. 2005. Vol. 96, N 3. P. 441–442.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Flisser A. J., Blaivas J. G. Role of cystometry in evaluating patients with overactive bladder // Urology. 2002. Vol.60, N 5. P. 33–42.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Ghei M., Malone-Lee J. Using the circumstances of symptom experience to assess the severity of urgency in the overactive bladder // J Urol. 2005. Vol.174, N 3. P. 972–976.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Herzog A. R., Diokno A. C., Fultz N. H. Urinary incontinence: medical and psychosocial aspects / In: Annual review of gerontology and geriatrics New York: Springer Publishing Company. 1989. Vol. 9. P. 77–119.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Homma Y., Yoshida M., Seki N. et al. Symptom assessment tool for overactive bladder syndrome — overactive bladder symptom score // Urology. 2006. Vol. 68, N 2. P. 318–323.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Irwin D. E., Milsom I., Hunskaar S. et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study // Eur Urol. 2006. Vol. 50, N 6. P. 1306–1314.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Kelleher C. J., Cardozo L. D., Khullar V., Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women // Br J Obstet Gynaecol. 1997. Vol. 104, N 9. P. 1374–1379.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Kobelt G. Economic considerations and outcome measurement in urge incontinence // Urology. 1997. Vol. 50, N 6A. P. 100–107.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Nixon A., Colman S., Sabounjian L. et al. A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials // J Urol. 2005. Vol.174, N 2. P. 604–647.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Papanicolaou S., Hunskaar S., Lose G., Sykes D. Assessment of bothersomeness and impact on quality of life of urinary incontinence in women in France, Germany, Spain and the UK // BJU Int. 2005. Vol. 96, N 6. P. 831–838.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Schafer W., Abrams P., Liao L. et al. Good urodynamic practice: uroflowmetry, filling cystometry, and pressure-flow studies // Neurourol Urodyn. 2002. Vol. 21. P. 261–274.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Stewart W. F., Van Rooyen J. B., Cundiff G. W. et al. Prevalence and burden of overactive bladder in the United States // World J Urol. 2003. Vol. 20, N 6. P. 327–336.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Tyagi S., Thomas C. A., Hayashi Y., Chancellor M. B. The overactive bladder: Epidemiology and morbidity // Urol Clin North Am. 2006. Vol. 33, N 4. P. 433–438.</mixed-citation></ref></ref-list></back></article>
